INVESTOR NEWS

Apr 16, 2021

Annual report 2020

The Board of Gentian Diagnostics AS has approved the Annual Report for 2020. The Annual Report is without..

Apr 16, 2021

First quarter 2021 report

Moss, 16 April 2021

Apr 12, 2021

Presentation of 2021 first quarter results for Gentian Diagnostics AS

Gentian Diagnostics AS will present its 2021 first quarter results on April 16th at 10.00 am. The..

Feb 18, 2021

Publication of NT-proBNP patent application

Feb 11, 2021

4Q 2020 Results and preliminary annual report

Moss, 11 February 2020 Gentian Diagnostics AS announces its results for the 4th quarter and 2020 preliminary..

Feb 05, 2021

Presentation of 2020 fourth quarter results for Gentian Diagnostics AS

Moss, 05 FEB 2021

Jan 22, 2021

SARS-CoV-2 antibody test moving to the next development phase

Moss, 22.01.2021 Gentian Diagnostics AS is pleased to announce that its high-throughput SARS-CoV-2 antibody..

Dec 15, 2020

Gentian Diagnostics presents at the DNB Nordic Healthcare Conference

Moss, 15.12.20

Dec 14, 2020

Gentian and research partners with two posters related to the value of calprotectin in management of COVID-19 patients at the AACC

Moss, 14.12.2020

Dec 09, 2020

Financial Calendar

Financial calendar for Gentian Diagnostics AS